Literature DB >> 12473281

Epidemiology of female genital Chlamydia trachomatis infections.

Jane Norman1.   

Abstract

The World Health Organization (WHO) has estimated that 92 million new cases of C. trachomatis (Chlamydia trachomatis) infection occur each year. This chapter focuses on the epidemiology of C. trachomatis infection, including the prevalence of infection in high- and low-risk groups, the incidence of infection, and data on secular trends. The evidence on the transmission of infection is reviewed. Risk factors for C. trachomatis infection in women are discussed. The adverse sequelae associated with C. trachomatis infection are described. Areas requiring further research are highlighted.

Entities:  

Mesh:

Year:  2002        PMID: 12473281     DOI: 10.1053/beog.2002.0325

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  12 in total

1.  Influence of different delivery modes on the clinical characteristics of Chlamydia trachomatis pneumonia.

Authors:  Jiejing Xu; Lili Yu; Baidi Fu; Deyu Zhao; Feng Liu
Journal:  Eur J Pediatr       Date:  2018-05-31       Impact factor: 3.183

2.  Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents.

Authors:  C Wang; J Tang; P A Crowley-Nowick; C M Wilson; R A Kaslow; W M Geisler
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  Chlamydia trachomatis infections in Greece: first prevalence study using nucleic acid amplification tests.

Authors:  S Levidiotou; G Vrioni; H Papadogeorgaki; K Avdeliodi; H Kada; G Kaparos; E Kouskouni; E Fragouli; N J Legakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-03       Impact factor: 3.267

4.  Association of anti-Chlamydia antibodies with ectopic pregnancy in Benin city, Nigeria: a case-control study.

Authors:  K Agholor; L Omo-Aghoja; F Okonofua
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

5.  Genital chlamydia trachomatis infection among female undergraduate students of University of Port Harcourt, Nigeria.

Authors:  A Ugboma Henry Arinze; Nwagwu Victor Onyebuchi; Jeremiah Isreal
Journal:  Niger Med J       Date:  2014-01

6.  The frequency of Neisseria gonorrhoeae endocervical infection among female carrier and changing trends of antimicrobial susceptibility patterns in Kashan, Iran.

Authors:  Shima Afrasiabi; Rezvan Moniri; Mansooreh Samimi; Seyed Gholamabbas Mousavi
Journal:  Iran J Microbiol       Date:  2014-06

7.  A Probiotic Adjuvant Lactobacillus rhamnosus Enhances Specific Immune Responses after Ocular Mucosal Immunization with Chlamydial Polymorphic Membrane Protein C.

Authors:  Aleksandra Inic-Kanada; Marijana Stojanovic; Emilija Marinkovic; Elisabeth Becker; Elisabeth Stein; Ivana Lukic; Radmila Djokic; Nadine Schuerer; Johannes H Hegemann; Talin Barisani-Asenbauer
Journal:  PLoS One       Date:  2016-09-16       Impact factor: 3.240

8.  The frequency of gonorrheal and chlamydial infections in Zanjanian women in 2013-2014.

Authors:  Behnaz Molaei; Farnaz Mohmmadian; Maryam Eftekhar; Robabeh Hatami; Atefe Tirkan; Mahsa Kiani
Journal:  Int J Reprod Biomed (Yazd)       Date:  2017-02

9.  Chlamydia trachomatis recombinant MOMP encapsulated in PLGA nanoparticles triggers primarily T helper 1 cellular and antibody immune responses in mice: a desirable candidate nanovaccine.

Authors:  Stacie J Fairley; Shree R Singh; Abebayehu N Yilma; Alain B Waffo; Praseetha Subbarayan; Saurabh Dixit; Murtada A Taha; Chino D Cambridge; Vida A Dennis
Journal:  Int J Nanomedicine       Date:  2013-05-30

10.  Urogenital Chlamydia trachomatis infections among ethnic groups in Paramaribo, Suriname; determinants and ethnic sexual mixing patterns.

Authors:  Jannie J van der Helm; Reinier J M Bom; Antoon W Grünberg; Sylvia M Bruisten; Maarten F Schim van der Loeff; Leslie O A Sabajo; Henry J C de Vries
Journal:  PLoS One       Date:  2013-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.